SCHEMBL22067400

SCHEMBL22067400

N#Cc1ccc2c(c1)c1cc(-c3ccc4c(c3)C3(c5cc(-c6ccc7c(c6)c6ccccc6n7-c6ccccc6)ccc5O4)c4cccnc4-c4ncccc43)ccc1n2-c1ccccc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DDB1 Q16531 1/20 0.33
▸ CRBN Q96SW2 1/20 0.33
▸ ABCC9 O60706 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.32
▸ ATM Q13315 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ PTGER4 P35408 1/20 0.32
▸ TDO2 P48775 2/20 0.31
▸ CCNB2 O95067 1/20 0.31
▸ CDK1 P06493 1/20 0.31
▸ CCNB1 P14635 1/20 0.31
▸ CCNA2 P20248 1/20 0.31
▸ CDK2 P24941 1/20 0.31
▸ GSK3A P49840 1/20 0.31
▸ GSK3B P49841 1/20 0.31
▸ CCNA1 P78396 1/20 0.31
▸ CDK5 Q00535 1/20 0.31
▸ CDK5R1 Q15078 1/20 0.31
▸ CCNB3 Q8WWL7 1/20 0.31
▸ GRM5 P41594 4/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22067104 0.99 DDB1 (0.33) DDB1CRBNABCC9KDM4EATM
SCHEMBL22067409 0.99 DDB1 (0.33) DDB1CRBNABCC9KDM4EATM
SCHEMBL22066059 0.99 DDB1 (0.33) DDB1CRBNABCC9KDM4EATM
SCHEMBL22067363 0.97 DDB1 (0.32) DDB1CRBNABCC9KDM4EATM
SCHEMBL22067380 0.97 DDB1 (0.32) DDB1CRBNABCC9KDM4EATM
SCHEMBL22067084 0.97 ABCC9 (0.34) DDB1CRBNABCC9KDM4EATM
SCHEMBL22067395 0.97 DDB1 (0.31) DDB1CRBNABCC9KDM4EATM
SCHEMBL22066055 0.96 DDB1 (0.31) DDB1CRBNABCC9
SCHEMBL22067105 0.96 DDB1 (0.31) DDB1CRBNABCC9
SCHEMBL22067080 0.96 DDB1 (0.33) DDB1CRBNABCC9PTGER4TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200185622-A1 Novel Compound, and Organic Light Emitting Device and Organic Light Emitting Display Device Including the Same DONGJIN SEMICHEM CO., LTD. (KR) 2020-06-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200185622-A1 Novel Compound, and Organic Light Emitting Device and Organic Light Emitting Display Device Including the Same ALDH1A2, DDT, TYR DDB1 387/4885CRBN 1937/4885ABCC9 3000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback